| Product Code: ETC7921546 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia`s small volume parenteral import shipments continued to show steady growth, with Lithuania, Netherlands, Switzerland, Poland, and Germany emerging as the top exporting countries. The market remained characterized by low concentration levels, as indicated by the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stood at 8.6%, reflecting a positive trend in the market. Moreover, the growth rate between 2023 and 2024 was recorded at 7.03%, underscoring the resilience and attractiveness of Latvia`s small volume parenteral market for international suppliers.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Small Volume Parenteral Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Small Volume Parenteral Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Small Volume Parenteral Market - Industry Life Cycle |
3.4 Latvia Small Volume Parenteral Market - Porter's Five Forces |
3.5 Latvia Small Volume Parenteral Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 Latvia Small Volume Parenteral Market Revenues & Volume Share, By Dose Type, 2021 & 2031F |
3.7 Latvia Small Volume Parenteral Market Revenues & Volume Share, By Packaging, 2021 & 2031F |
3.8 Latvia Small Volume Parenteral Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Latvia Small Volume Parenteral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for injectable drugs due to the rise in chronic diseases and geriatric population. |
4.2.2 Advancements in healthcare infrastructure and technology in Latvia. |
4.2.3 Growing focus on home healthcare services leading to a rise in the usage of small volume parenteral products. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and manufacturing of small volume parenteral products. |
4.3.2 Competition from alternative drug delivery methods such as oral medications. |
4.3.3 Price sensitivity among consumers and healthcare providers. |
5 Latvia Small Volume Parenteral Market Trends |
6 Latvia Small Volume Parenteral Market, By Types |
6.1 Latvia Small Volume Parenteral Market, By Form |
6.1.1 Overview and Analysis |
6.1.2 Latvia Small Volume Parenteral Market Revenues & Volume, By Form, 2021- 2031F |
6.1.3 Latvia Small Volume Parenteral Market Revenues & Volume, By Liquid, 2021- 2031F |
6.1.4 Latvia Small Volume Parenteral Market Revenues & Volume, By Dry, 2021- 2031F |
6.2 Latvia Small Volume Parenteral Market, By Dose Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Small Volume Parenteral Market Revenues & Volume, By Single-dose, 2021- 2031F |
6.2.3 Latvia Small Volume Parenteral Market Revenues & Volume, By Multiple-dose, 2021- 2031F |
6.3 Latvia Small Volume Parenteral Market, By Packaging |
6.3.1 Overview and Analysis |
6.3.2 Latvia Small Volume Parenteral Market Revenues & Volume, By Ampoules, 2021- 2031F |
6.3.3 Latvia Small Volume Parenteral Market Revenues & Volume, By Vials, 2021- 2031F |
6.3.4 Latvia Small Volume Parenteral Market Revenues & Volume, By Pre-filled Syringes, 2021- 2031F |
6.3.5 Latvia Small Volume Parenteral Market Revenues & Volume, By Cartridges, 2021- 2031F |
6.3.6 Latvia Small Volume Parenteral Market Revenues & Volume, By Bottles, 2021- 2031F |
6.3.7 Latvia Small Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Latvia Small Volume Parenteral Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 Latvia Small Volume Parenteral Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.4.3 Latvia Small Volume Parenteral Market Revenues & Volume, By Cancer Care, 2021- 2031F |
6.4.4 Latvia Small Volume Parenteral Market Revenues & Volume, By Malnourishment, 2021- 2031F |
6.4.5 Latvia Small Volume Parenteral Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.4.6 Latvia Small Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Small Volume Parenteral Market Import-Export Trade Statistics |
7.1 Latvia Small Volume Parenteral Market Export to Major Countries |
7.2 Latvia Small Volume Parenteral Market Imports from Major Countries |
8 Latvia Small Volume Parenteral Market Key Performance Indicators |
8.1 Average length of hospital stay for patients receiving small volume parenteral products. |
8.2 Number of healthcare facilities offering small volume parenteral products. |
8.3 Percentage of healthcare professionals trained in the proper administration of small volume parenteral products. |
9 Latvia Small Volume Parenteral Market - Opportunity Assessment |
9.1 Latvia Small Volume Parenteral Market Opportunity Assessment, By Form, 2021 & 2031F |
9.2 Latvia Small Volume Parenteral Market Opportunity Assessment, By Dose Type, 2021 & 2031F |
9.3 Latvia Small Volume Parenteral Market Opportunity Assessment, By Packaging, 2021 & 2031F |
9.4 Latvia Small Volume Parenteral Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Latvia Small Volume Parenteral Market - Competitive Landscape |
10.1 Latvia Small Volume Parenteral Market Revenue Share, By Companies, 2024 |
10.2 Latvia Small Volume Parenteral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here